[
    [
        {
            "time": "2019-01-08",
            "original_text": "Takeaways From The JPMorgan Healthcare Conference",
            "features": {
                "keywords": [
                    "JPMorgan",
                    "Healthcare",
                    "Conference"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Takeaways From The JPMorgan Healthcare Conference",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-08",
            "original_text": "Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates",
            "features": {
                "keywords": [
                    "Pharma",
                    "LLY",
                    "Dermira",
                    "Buyout",
                    "Pipeline",
                    "Regulatory"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-01-08",
            "original_text": "Novo Nordisk's Ozempic Gets FDA Nod for CV Risk Reduction",
            "features": {
                "keywords": [
                    "Novo",
                    "Nordisk",
                    "Ozempic",
                    "FDA",
                    "CV",
                    "Risk",
                    "Reduction"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novo Nordisk's Ozempic Gets FDA Nod for CV Risk Reduction",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]